Edition:
United Kingdom

NanJing Pharmaceutical Co Ltd (600713.SS)

600713.SS on Shanghai Stock Exchange

6.45CNY
6:59am GMT
Change (% chg)

¥0.15 (+2.38%)
Prev Close
¥6.30
Open
¥6.33
Day's High
¥6.47
Day's Low
¥6.33
Volume
5,713,512
Avg. Vol
4,068,823
52-wk High
¥8.45
52-wk Low
¥6.13

Chart for

About

Nanjing Pharmaceutical Company Limited is principally engaged in manufacture and distribution of Chinese medicines and western drugs. The Company operates its businesses primarily through pharmaceutical distribution, which involves in operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management... (more)

Overall

Beta: 1.10
Market Cap(Mil.): ¥6,326.85
Shares Outstanding(Mil.): 897.43
Dividend: 0.05
Yield (%): 0.64

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Nanjing Pharmaceutical signs letter of intent on medical welfare management project

* Says it signed letter of intent with Wanhu Health, a PBM company, to cooperate on medical welfare management project related business through technology JV and Welfare Management Center for patients with chronic diseases

09 Oct 2017

BRIEF-Nanjing Pharmaceutical issues 2017 1st tranche super short-term financing notes worth 2 bln yuan

* Says it issued 2017 1st tranche super short-term financing notes worth 2 billion yuan with a term of 90 days and interest rate of 4.5 percent

31 Jul 2017

BRIEF-Nanjing Pharmaceutical to sell 9 pct stake in China Healthcare Supply Chain Service for 12.5 mln yuan

* Says it plans to sell 9 percent stake in China Healthcare Supply Chain Service Co Ltd for 12.5 million yuan

26 Jul 2017

BRIEF-Nanjing Pharmaceutical to acquire shares in three medicine related firms

* Says it plans to acquire 20 percent stake in Jiang Su Hua Xiao Pharmal Euhcal Lugisinls Co Ltd

26 Jul 2017

Earnings vs. Estimates